Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles. (Q34519657)

PubMed publication ID

2 August 2017

1 reference

title

Donepezil for Alzheimer's disease: pharmacodynamic, pharmacokinetic, and clinical profiles (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

12 May 2020

0 references

1 reference

1 reference

M Shigeta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

12 May 2020

A Homma

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

12 May 2020

publication date

1 January 2001

1 reference

PubMed publication ID

11830754

CNS Neuroscience & Therapeutics

2 August 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

12 May 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

12 May 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

12 May 2020

page(s)

353-368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

[Discovery and development of donepezil hydrochloride for the treatment of Alzheimer's disease]

12 May 2020

cites work

1 reference

12 December 2020

Cholinergic therapy for Down's syndrome

1 reference

12 December 2020

The effects of donepezil in Alzheimer's disease - results from a multinational trial.

1 reference

12 December 2020

Realistic expectations for the management of Alzheimer's disease

1 reference

12 December 2020

Clinical benefits of a new piperidine-class AChE inhibitor

1 reference

12 December 2020

Use of donepezil for vascular dementia: preliminary clinical experience

1 reference

12 December 2020

Donepezil in treatment-resistant bipolar disorder.

1 reference

12 December 2020

Brain injury, cognitive impairment, and donepezil.

1 reference

12 December 2020

Donepezil for Tourette's disorder and ADHD

1 reference

12 December 2020

Donepezil for Huntington's disease

1 reference

12 December 2020

Donepezil for the treatment of psychosis in dementia with Lewy bodies

1 reference

12 December 2020

Donepezil for behavioural disorders associated with Lewy bodies: a case series

1 reference

12 December 2020

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: final analysis of a US multicentre open-label study

1 reference

12 December 2020

Donepezil: a review of its use in Alzheimer's disease

1 reference

12 December 2020

A 12-week, open trial of donepezil hydrochloride in patients with multiple sclerosis and associated cognitive impairments

1 reference

12 December 2020

Donepezil in the treatment of cognitive dysfunction associated with traumatic brain injury

1 reference

12 December 2020

Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: a preliminary study

1 reference

12 December 2020

Treatment of REM sleep behavior disorder with donepezil: a report of three cases

1 reference

12 December 2020

Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group

1 reference

12 December 2020

Adjunctive donepezil in attention deficit hyperactivity disorder youth: case series

1 reference

12 December 2020

Review of the acetylcholinesterase inhibitor galanthamine

1 reference

12 December 2020

Donepezil for Down's syndrome

1 reference

12 December 2020

Non-stimulant treatments for ADHD.

1 reference

12 December 2020

Improvement in sundowning in dementia with Lewy bodies after treatment with donepezil

1 reference

12 December 2020

Successful use of donepezil for the treatment of dementia with Lewy bodies

1 reference

12 December 2020

Effects of anticholinesterase drugs tacrine and E2020, the 5-HT(3) antagonist ondansetron, and the H(3) antagonist thioperamide, in models of cognition and cholinergic function.

1 reference

12 December 2020

Open-label, multicenter, phase 3 extension study of the safety and efficacy of donepezil in patients with Alzheimer disease

1 reference

12 December 2020

VIP and peptides related to activity-dependent neurotrophic factor protect PC12 cells against oxidative stress

1 reference

12 December 2020

1 reference

12 December 2020

Mild senile dementia of the Alzheimer type. 4. Evaluation of intervention.

1 reference

12 December 2020

Quantitative structure-activity relationship. QSAR, analyses of the substituted indanone and benzylpiperidine rings of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase

1 reference

12 December 2020

Conformational analyses and molecular-shape comparisons of a series of indanone-benzylpiperidine inhibitors of acetylcholinesterase

1 reference

12 December 2020

Novel piperidine derivatives. Synthesis and anti-acetylcholinesterase activity of 1-benzyl-4-[2-(N-benzoylamino)ethyl]piperidine derivatives

1 reference

12 December 2020

Clinical predictors of course for Alzheimer patients in a longitudinal study: a preliminary report

1 reference

12 December 2020

Apolipoprotein E polymorphism in health and disease

1 reference

12 December 2020

Oral physostigmine treatment of patients with Alzheimer's disease

1 reference

12 December 2020

Experimental pharmacology of Alzheimer disease

1 reference

12 December 2020

Oral physostigmine and lecithin improve memory in Alzheimer disease

1 reference

12 December 2020

A new rating scale for Alzheimer's disease.

1 reference

12 December 2020

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

12 December 2020

A new clinical scale for the staging of dementia.

1 reference

12 December 2020

A new rating scale for dementia syndromes

1 reference

12 December 2020

Effects of (-)-S-2,8-dimethyl-3-methylene-1-oxa-8-azaspiro[4,5]decane L-tartrate monohydrate (YM796), a novel muscarinic agonist, on disturbance of passive avoidance learning behavior in drug-treated and senescence-accelerated mice.

1 reference

12 December 2020

Synthesis and structure-activity relationships of acetylcholinesterase inhibitors: 1-benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine hydrochloride and related compounds

1 reference

12 December 2020

Effects of the centrally acting cholinesterase inhibitors tetrahydroaminoacridine and E2020 on the basal concentration of extracellular acetylcholine in the hippocampus of freely moving rats

1 reference

12 December 2020

Characterization of a novel muscarinic receptor agonist, YM796: comparison with cholinesterase inhibitors in in vivo pharmacological studies

1 reference

12 December 2020

Tacrine: first drug approved for Alzheimer's disease

1 reference

12 December 2020

Emerging drugs for Alzheimer's disease. Mechanisms of action and prospects for cognitive enhancing medications.

1 reference

12 December 2020

Acetylcholinesterase protection and the anti-diisopropylfluorophosphate efficacy of E2020.

1 reference

12 December 2020

A longitudinal study of Alzheimer's disease: measurement, rate, and predictors of cognitive deterioration

1 reference

12 December 2020

Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects

1 reference

12 December 2020

Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers.

1 reference

12 December 2020

Kinetic study on the inhibition of acetylcholinesterase by 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine hydrochloride (E2020).

1 reference

12 December 2020

Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease

1 reference

12 December 2020

Maximizing function in Alzheimer's disease: what role for tacrine?

1 reference

12 December 2020

The effect of the selective reversible acetylcholinesterase inhibitor E2020 on extracellular acetylcholine and biogenic amine levels in rat cortex

1 reference

12 December 2020

An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors.

1 reference

12 December 2020

Cholinergic improvement of a naturally-occurring memory deficit in the young rat.

1 reference

12 December 2020

The efficacy and safety of donepezil in patients with Alzheimer's disease: results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial. The Donepezil Study Group.

1 reference

12 December 2020

Practice guideline for the treatment of patients with Alzheimer's disease and other dementias of late life. American Psychiatric Association

1 reference

12 December 2020

Effects of NIK-247 on cholinesterase and scopolamine-induced amnesia

1 reference

12 December 2020

Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study

1 reference

12 December 2020

Potential Role of Muscarinic Agonists in Alzheimerʼs Disease

1 reference

12 December 2020

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease

1 reference

12 December 2020

Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open label extension study

1 reference

12 December 2020

Donepezil Use in Alzheimer Disease

1 reference

12 December 2020

Donepezil mediated memory improvement in traumatic brain injury during post acute rehabilitation

1 reference

12 December 2020

Donepezil improves cognition and global function in Alzheimer disease: a 15-week, double-blind, placebo-controlled study. Donepezil Study Group

1 reference

12 December 2020

Comparative studies of huperzine A, E2020, and tacrine on behavior and cholinesterase activities

1 reference

12 December 2020

Reversal of scopolamine-induced deficits in radial maze performance by (-)-huperzine A: comparison with E2020 and tacrine

1 reference

12 December 2020

Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients

1 reference

12 December 2020

Dementia with Lewy bodies: response of delirium-like features to donepezil.

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following single oral doses

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following multiple oral doses

1 reference

12 December 2020

Pharmacokinetic and pharmacodynamic profile of donepezil HCl following evening administration

1 reference

12 December 2020

Metabolism and elimination of 14C-donepezil in healthy volunteers: a single-dose study

1 reference

12 December 2020

Concurrent administration of donepezil HCl and cimetidine: assessment of pharmacokinetic changes following single and multiple doses

1 reference

12 December 2020

Concurrent administration of donepezil HCl and ketoconazole: assessment of pharmacokinetic changes following single and multiple doses

1 reference

12 December 2020

Concurrent administration of donepezil HCl and theophylline: assessment of pharmacokinetic changes following multiple-dose administration in healthy volunteers

1 reference

12 December 2020

Concurrent administration of donepezil HCl and digoxin: assessment of pharmacokinetic changes

1 reference

12 December 2020

The effect of multiple doses of donepezil HCl on the pharmacokinetic and pharmacodynamic profile of warfarin

1 reference

12 December 2020

An evaluation of the pharmacokinetics of donepezil HCl in patients with impaired hepatic function

1 reference

12 December 2020

An evaluation of the pharmacokinetics of donepezil HCl in patients with moderately to severely impaired renal function

1 reference

12 December 2020

Perspectives in the management of Alzheimer's disease: clinical profile of donepezil

1 reference

12 December 2020

Clinical profile of donepezil in the treatment of Alzheimer's disease.

1 reference

12 December 2020

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

1 reference

12 December 2020

Donepezil improves symptoms of delirium in dementia: implications for future research

1 reference

12 December 2020

10.1111/J.1527-3458.2001.TB00204.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

12 May 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6741644&resulttype=core&format=json

12 May 2020

PubMed publication ID

11830754

1 reference